Triplepoint Venture Growth BDC Corp. TPVG 深 滬
已收盤 09-05 16:00:00 美东时间
6.83
+0.030
+0.44%
華盛通- 最 高6.88
- 今 開6.86
- 成交量 23.23万股
- 最 低 6.74
- 昨 收 6.80
- 總市值 2.75亿
- 52周最高 7.60
- 市盈率 靜 8.33
- 換手率 0.58%
- 52周最低 5.23
- 委 比 -33.33%
- 總股本 4032.37万
- 歷史最高 13.74
- 量 比 0.66
- 振 幅 2.06%
- 歷史最低 -5.16
- 每 手 1
- 風險率 1.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多TriplePoint Venture Growth BDC declares $0.23 dividend
TriplePoint Venture Growth BDC (NYSE:TPVG) declares $0.23/share quarterly dividend. Forward yield 14.51% Payable Sept. 30; for shareholders of record Sept. 16; ex-div Sept. 16. See TPVG Dividend Score...
08-08 22:52
TriplePoint Venture Gwth Q2 EPS $0.28 Misses $0.31 Estimate, Sales $23.28M Miss $23.79M Estimate
TriplePoint Venture Gwth (NYSE:TPVG) reported quarterly earnings of $0.28 per share which missed the analyst consensus estimate of $0.31 by 8.5 percent. This is a 15.15 percent decrease over earnings of $0.33 per share
08-07 04:19
Earnings Scheduled For August 6, 2025
Companies Reporting Before The Bell • Lineage (NASDAQ:LINE) is likely to report...
08-06 16:33
UBS Maintains Neutral on TriplePoint Venture Gwth, Raises Price Target to $7
UBS analyst Vilas Abraham maintains TriplePoint Venture Gwth (NYSE:TPVG) with a Neutral and raises the price target from $6.5 to $7.
07-16 23:49
TriplePoint Venture Gwth Q1 EPS $0.27 Misses $0.31 Estimate, Sales $22.45M Miss $24.81M Estimate
TriplePoint Venture Gwth (NYSE:TPVG) reported quarterly earnings of $0.27 per share which missed the analyst consensus estimate of $0.31 by 12.9 percent. This is a 34.15 percent decrease over earnings of $0.41 per share
05-08 04:24
快讯 | Triplepoint创业公司增长第一季度净资产值 美元指数 34700万
Triplepoint Venture Growth Q1 Net Asset Value USD 347 Million
05-08 04:15
Earnings Scheduled For May 7, 2025
Companies Reporting Before The Bell • Wallbox (NYSE:WBX) is estimated to report...
05-07 16:33
美股大行评级 | 潜在涨幅89.34%！Loop Capital上调Warby Parker目标价至27美元，评级升至"买入"
每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。
04-18 08:48
美股大行评级 | 超多美股遭下调评级！高盛：下调美国航空集团评级至"卖出"，目标价从16美元下调至8美元
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1117013356914663424.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持FTC Solar(FTCI)"买入"评级，目标价从1.5美元升至5美元</p> <p>• 摩根士丹利：维持艾伯维(ABBV)"超配"评级，目标价从239美元升至241美
04-10 09:00
美股大行评级 | 潜在涨幅147.43%！HC Wainwright & Co.上调Pacira BioSciences目标价至65美元，维持"买入"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1116650478822592513.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• HC Wainwright & Co.：维持Pacira BioSciences(PCRX)"买入"评级，目标价从48美元升至65美元</p> <p>• 瑞穗：上调Amylyx Pharmaceuticals(AM
04-09 08:50
